Photo taken from Erika Hamilton/X
Jun 24, 2024, 13:33
Erika Hamilton’s insights into the future of ADCs in oncology – Sarah Cannon Research Institute
Sarah Cannon Research Institute shared the following post on LinkedIn:
“We are thrilled to share the latest advancements in cancer research from our experts at Sarah Cannon Research Institute, presented at the 2024 Annual ASCO Meeting. Erika Hamilton, MD’s insights into the future of antibody-drug conjugates (ADCs) highlight exciting new possibilities in oncology. Discover more about these therapies here.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 09:22
Dec 21, 2024, 09:06
Dec 21, 2024, 09:00
Dec 21, 2024, 08:51
Dec 21, 2024, 08:48
Dec 21, 2024, 08:42
Dec 21, 2024, 08:37
Dec 21, 2024, 08:29
Dec 21, 2024, 08:12